AstraZeneca is a global, science-led, patient-focused biopharmaceutical company dedicated to discovering, developing, and commercializing prescription medicines for serious diseases. Within Hematology R&D, the team is committed to advancing science to deliver life-changing medicines for patients in need. The Hematology Research and Early Development (R&D) team is responsible for all drug development activities in hematology research, from first-in-man studies to late-stage trials leading to regulatory approval (Phase 1, 2, and 3). The team aims to deliver compelling preclinical, clinical, and translational data packages to support investment in late-stage clinical development and drug approval. This role is for a highly qualified Global Clinical Program Lead (GCPL) to lead the clinical development and execution of product strategy for multiple projects. The individual will be accountable for the strategic clinical development plan and clinical execution of compounds, reporting to the Global Clinical Head (GCH) of the disease indication. They will articulate project goals, strategy, science, and clinical need to internal and external audiences. The role involves working with other project leaders, scientific and clinical leaders, and external experts to coordinate integrated project plans across functional boundaries. The candidate will ensure diverse views are heard, foster an empowered and motivated team, and demonstrate visible leadership within the oncology community. The successful candidate will possess hematology/oncology clinical drug development experience, demonstrated leadership, and the ability to critically navigate the underlying science. Effective communication across a broad range of audiences and clear articulation of project-specific and overall oncology strategies are essential.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree